Long-term pioglitazone use doubles bladder cancer risk Epidemiology population study 14 January 2013 Pages: 1 - 1
Saccharomyces boulardii probiotic treatment may not be effective at preventing antibiotic-associated diarrhoea (AAD), Clinical study 14 January 2013 Pages: 2 - 2
A “substantial“ number of patients taking modified-release high-potency opioids (HPOs) may be at risk of interactions with alcohol, Clinical study 14 January 2013 Pages: 2 - 2
Misuse of prescription analgesics starts early in US youths Incidence study 14 January 2013 Pages: 3 - 3
Corticosteroids inhibit fetal growth, have long-term CV effects News item 14 January 2013 Pages: 3 - 3
The UK MHRA has issued an alert to healthcare professionals following the precautionary recall of Anapen epinephrine [adrenaline] injector by Lincoln Medical Limited. Media release 14 January 2013 Pages: 4 - 4
Chiesi Limited has issued a 'Dear Healthcare Professional' letter regarding the safe use of caffeine citrate [Peyona] 20 mg/mL ampoules News item 14 January 2013 Pages: 4 - 4
The Australian Therapeutic Goods Administration (TGA) has started work on its planned reforms to the regulation of complementary medicines. Media release 14 January 2013 Pages: 4 - 4
The European Medicines Agency (EMA) has launched a new public website for adverse drug reaction (ADR) reporting. Media release 14 January 2013 Pages: 4 - 4
New safety information regarding the risks of serious hypersensitivity reactions has been added to the UK labelling for Adenuric [febuxostat], News item 14 January 2013 Pages: 5 - 5
The risk of keratitis previously identified with panitumumab* is now considered a class effect for all epidermal growth factor receptor (EGFR) inhibitors, News item 14 January 2013 Pages: 5 - 5
The European Medicines Agency (EMA) CHMP has published a position paper on medication errors News item 14 January 2013 Pages: 5 - 5
